Victory Capital Management
TXG icon

Victory Capital Management’s 10x Genomics TXG Stock Holding History

Victory Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Sell
12,893
-9
-0.1% -$180 ﹤0.01% 2140
2025
Q4 		$210K Buy
12,902
+186
+1% +$2.81K ﹤0.01% 2194
2025
Q3 		$149K Buy
12,716
+379
+3% +$4.94K ﹤0.01% 2252
2025
Q2 		$143K Buy
12,337
+101
+0.8% +$921 ﹤0.01% 2295
2025
Q1 		$107K Sell
12,236
-102
-0.8% -$1.29K ﹤0.01% 2303
2024
Q4 		$177K Sell
12,338
-299
-2% -$4.72K ﹤0.01% 2261
2024
Q3 		$285K Sell
12,637
-91
-0.7% -$1.88K ﹤0.01% 2149
2024
Q2 		$248K Sell
12,728
-203
-2% -$5.32K ﹤0.01% 2150
2024
Q1 		$485K Buy
12,931
+193
+2% +$8.48K ﹤0.01% 1991
2023
Q4 		$713K Buy
12,738
+2,515
+25% +$109K ﹤0.01% 1862
2023
Q3 		$422K Sell
10,223
-16,261
-61% -$846K ﹤0.01% 2038
2023
Q2 		$1.48M Sell
26,484
-1,241
-4% -$67.2K ﹤0.01% 1500
2023
Q1 		$1.55M Buy
27,725
+18,017
+186% +$841K ﹤0.01% 1481
2022
Q4 		$354K Sell
9,708
-5
-0.1% -$163 ﹤0.01% 2122
2022
Q3 		$277K Buy
+9,713
New +$370K ﹤0.01% 2277
2022
Q1 		– Sell
-23,560
Closed -$3.51M – 2811
2021
Q4 		$3.51M Sell
23,560
-21,455
-48% -$3.29M ﹤0.01% 1405
2021
Q3 		$6.55M Sell
45,015
-8,584
-16% -$1.47M 0.01% 1247
2021
Q2 		$10.5M Sell
53,599
-124,652
-70% -$22.6M 0.01% 1108
2021
Q1 		$32.3M Sell
178,251
-2,381
-1% -$411K 0.03% 734
2020
Q4 		$25.6M Sell
180,632
-23,584
-12% -$3.42M 0.03% 776
2020
Q3 		$25.5M Sell
204,216
-27,053
-12% -$2.84M 0.03% 691
2020
Q2 		$20.7M Sell
231,269
-485,209
-68% -$37.8M 0.03% 765
2020
Q1 		$44.6M Buy
716,478
+261,584
+58% +$20.4M 0.04% 614
2019
Q4 		$34.7M Sell
454,894
-106,780
-19% -$6.42M 0.04% 622
2019
Q3 		$28.3M Buy
+561,674
New +$31.1M 0.04% 665

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management's TXG Position: Q1 2026 in Review

Victory Capital Management reduced its 10x Genomics (TXG) stake by 0.07% in Q1 2026, selling an estimated $180 and leaving 12,893 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2140.

Victory Capital Management first reported a position in TXG in Q3 2019 and has held it in 25 quarters since. The position peaked at $44.6M in Q1 2020. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Victory Capital Management held 12,893 shares of 10x Genomics worth $274K as of Q1 2026.
  • Victory Capital Management sold 9 10x Genomics shares in Q1 2026, an estimated $180.
  • 10x Genomics made up ﹤0.01% of Victory Capital Management's portfolio in Q1 2026, its #2140 holding.
  • Victory Capital Management first reported a position in 10x Genomics in Q3 2019 and has held it in 25 quarters since.
  • Victory Capital Management's 10x Genomics position peaked at $44.6M in Q1 2020.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.